1887
Preview this article:
Zoom in
Zoomout

Comparing apples and oranges: considerations for quantifying candidal biofilms with XTT [2,3-bis(2-methoxy-4-nitro-5-sulfo-phenyl)-2H-tetrazolium-5-carboxanilide] and the need for standardized testing, Page 1 of 1

| /docserver/preview/fulltext/jmm/65/4/259_jmm000237-1.gif

There is no abstract available for this article.
Use the preview function to the left.

Loading

Article metrics loading...

/content/journal/jmm/10.1099/jmm.0.000237
2016-04-01
2019-12-07
Loading full text...

Full text loading...

/deliver/fulltext/jmm/65/4/259.html?itemId=/content/journal/jmm/10.1099/jmm.0.000237&mimeType=html&fmt=ahah

References

  1. Dhale R. P., Ghorpade M. V., Dharmadhikari C. A.. ( 2014;). Comparison of various methods used to detect biofilm production of Candida species. J Clin Diagn Res 8: DC18-c20 [PubMed].
    [Google Scholar]
  2. Hawser S.. ( 1996a;). Adhesion of different Candida spp. to plastic: XTT formazan determinations. J Med Vet Mycol 34: 407–410 [CrossRef] [PubMed].
    [Google Scholar]
  3. Hawser S.. ( 1996b;). Comparisons of the susceptibilities of planktonic and adherent Candida albicans to antifungal agents: a modified XTT tetrazolium assay using synchronised C. albicans cells. J Med Vet Mycol 34: 149–152 [CrossRef] [PubMed].
    [Google Scholar]
  4. Hawser S. P., Norris H., Jessup C. J., Ghannoum M. A.. ( 1998;). Comparison of a 2,3-bis(2-methoxy-4-nitro-5-sulfophenyl)-5-[(phenylamino)carbonyl]-2H-tetrazolium hydroxide (XTT) colorimetric method with the standardized National Committee for Clinical Laboratory Standards method of testing clinical yeast isolates for susceptibility to antifungal agents. J Clin Microbiol 36: 1450–1452 [PubMed].
    [Google Scholar]
  5. Kuhn D. M., Balkis M., Chandra J., Mukherjee P. K., Ghannoum M. A.. ( 2003;). Uses and limitations of the XTT assay in studies of Candida growth and metabolism. J Clin Microbiol 41: 506–508 [CrossRef] [PubMed].
    [Google Scholar]
  6. Marcos-Zambrano L. J., Escribano P., Bouza E., Guinea J.. ( 2014;). Production of biofilm by Candida and non-Candida spp. isolates causing fungemia: comparison of biomass production and metabolic activity and development of cut-off points. Int J Med Microbiol 304: 1192–1198 [CrossRef] [PubMed].
    [Google Scholar]
  7. Pierce C. G., Uppuluri P., Tristan A. R., Wormley F. L. Jr, Mowat E., Ramage G., Lopez-Ribot J. L.. ( 2008;). A simple and reproducible 96-well plate-based method for the formation of fungal biofilms and its application to antifungal susceptibility testing. Nat Protoc 3: 1494–1500 [CrossRef] [PubMed].
    [Google Scholar]
  8. Pongrácz J., Benedek K., Juhász E., Iván M., Kristóf K.. ( 2015;). In vitro biofilm production of Candida bloodstream isolates: any association with clinical characteristics. J Med Microbiol [CrossRef] (In Press). [PubMed].
    [Google Scholar]
  9. Rajendran R., Sherry L., Nile C. J., Sherriff A., Johnson E. M., Hanson M. F., Williams C., Munro C. A., Jones B. J., Ramage G.. ( 2016;). Biofilm formation is a risk factor for mortality in patients with Candida albicans bloodstream infection - Scotland, 2012-2013. Clin Microbiol Infect 22: 87–93 [CrossRef] [PubMed].
    [Google Scholar]
  10. Ramage G., Vande Walle K., Wickes B. L., López-Ribot J. L.. ( 2001;). Standardized method for in vitro antifungal susceptibility testing of Candida albicans biofilms. Antimicrob Agents Chemother 45: 2475–2479 [CrossRef] [PubMed].
    [Google Scholar]
  11. Taff H. T., Nett J. E., Andes D. R.. ( 2012;). Comparative analysis of Candida biofilm quantitation assays. Med Mycol 50: 214–218 [CrossRef] [PubMed].
    [Google Scholar]
  12. Tellier R., Krajden M., Grigoriew G. A., Campbell I.. ( 1992;). Innovative endpoint determination system for antifungal susceptibility testing of yeasts. Antimicrob Agents Chemother 36: 1619–1625 [CrossRef] [PubMed].
    [Google Scholar]
  13. Thein Z. M., Samaranayake Y. H., Samaranayake L. P.. ( 2007;). In vitro biofilm formation of Candida albicans and non-albicans Candida species under dynamic and anaerobic conditions. Arch Oral Biol 52: 761–767 [CrossRef] [PubMed].
    [Google Scholar]
  14. Tumbarello M., Posteraro B., Trecarichi E. M., Fiori B., Rossi M., Porta R., de Gaetano Donati K., La Sorda M., Spanu T., other authors. ( 2007;). Biofilm production by Candida species and inadequate antifungal therapy as predictors of mortality for patients with candidemia. J Clin Microbiol 45: 1843–1850 [CrossRef] [PubMed].
    [Google Scholar]
  15. Tumbarello M., Fiori B., Trecarichi E. M., Posteraro P., Losito A. R., De Luca A., Sanguinetti M., Fadda G., Cauda R., Posteraro B.. ( 2012;). Risk factors and outcomes of candidemia caused by biofilm-forming isolates in a tertiary care hospital. PLoS One 7: e33705 [CrossRef] [PubMed].
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jmm/10.1099/jmm.0.000237
Loading
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error